https://www.marketscreener.com/quote/stock/GSK-PLC-9590199/news/Gsk-Preclinical-data-demonstrate-sotrovimab-retains-activity-against-key-Omicron-mutations-new-SA-37204865/?utm_source=telegram&utm_medium=social&utm_campaign=share